Ozempic rose from a 10 th place ranking among the 10 top-selling Part D drugs in 2021, with gross spending of $2.6 billion, to 6 th place in 2022, with spending of $4.6 billion (Figure 2)
The SUSTAIN and STEP trial programs, which established semaglutide's efficacy for diabetes management and weight loss respectively, did not identify specific safety concerns related to concomitant blood thinner use
There was also a difference in weight loss between participants with type 2 diabetes and those without, so more research can look at differences between these groups such as engagement in other weight loss activities and other underlying reasons
Without dietary intervention, subjects may choose high-calorie options and end up consuming more energy than what is optimal for maximizing healthy weight loss
How do you qualify for semaglutide for weight loss
Heres how most people progress through their doses: Begin with 0.25 mg weekly injections